Balyasny Asset Management LLC Singular Genomics Systems, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.78 - $1.28 $10,839 - $17,788
13,897 New
13,897 $11,000
Q3 2022

Nov 14, 2022
BUY
$2.5 - $4.73 $26,277 - $49,717
10,511 New
10,511 $26,000

Others Institutions Holding OMIC

# of Institutions
2
Shares Held
1.43M
Call Options Held
0
Put Options Held
0
View Full List

About Singular Genomics Systems, Inc.

OMIC Quotes by TradingView
  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $1.52B
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email